1994
DOI: 10.1007/bf03010016
|View full text |Cite
|
Sign up to set email alerts
|

Succinylcholine warning

Abstract: CORRESPONDENCE 657sidered to be at high risk of regurgitation and aspiration. However, whilst the OTC probably offers increased airway protection, its value has not been proved in this clinical situation. The LMA does not protect the trachea from regurgitated stomach contents, but has been shown, by Baraka amongst others, 4 to be life-saving on occasions where tracheal intubation and FM ventilation have both failed. The risk/benefit ratios of these two devices have not been assessed and it is premature to pres… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1995
1995
2018
2018

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 1 publication
0
1
0
Order By: Relevance
“…Most importantly, controversy remains regarding the administration of succinylcholine. While its routine use is not recommended due to concerns of hyperkalemia in patients with undiagnosed myopathy, the manufacturer's package insert still describes its use for emergency tracheal intubation or in instances where immediate securing of the airway is necessary [28][29][30].…”
Section: Discussionmentioning
confidence: 99%
“…Most importantly, controversy remains regarding the administration of succinylcholine. While its routine use is not recommended due to concerns of hyperkalemia in patients with undiagnosed myopathy, the manufacturer's package insert still describes its use for emergency tracheal intubation or in instances where immediate securing of the airway is necessary [28][29][30].…”
Section: Discussionmentioning
confidence: 99%